13553-79-2: Rifaximin EP Impurity E

Status: In-stock

It is an impurity of Rifaximin. Rifaximin is employed to treat the symptoms of Traveler’s Diarrhea caused by Escherichia coli, Hepatic Encephalopathy, and Irritable Bowel Syndrome with diarrhea.

Additional information on CAS 13553-79-2

Catalogue No. VL4360004
CAS No. 13553-79-2
Molecular Formula C37H45NO12
Molecular Weight 695.76
Parent drug Rifaximin
IUPAC Name 5, 17, 19, 21-Tetrahydroxy-23-methoxy-2, 4, 12, 16, 18, 20, 22-heptamethyl-2, 7-(epoxypentadeca[1, 11, 13]trienimino)naphtho[2, 1-b]furan-1, 6, 9, 11(2H)-tetrone 21-Acetate
Synonyms Rifaximin BP Impurity E; Rifamycin S; Rifamycin EP Impurity B; 5, 17, 19, 21-Tetrahydroxy-23-methoxy-2, 4, 12, 16, 18, 20, 22-heptamethyl-2, 7-(epoxypentadeca[1, 11, 13]trienimino)naphtho[2, 1-b]furan-1, 6, 9, 11(2H)-tetrone 21-Acetate; 1, 4-Dideoxy-1, 4-dihydro-1, 4-dioxo-rifamycin; Rifaximin EP Impurity E
References “Sci-Hub, Rifaximin Treatment in Hepatic Encephalopathy, 10.1056/NEJMoa0907893.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1056/NEJMoa0907893.
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

13553-79-2: Rifaximin EP Impurity E

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden
This field is for validation purposes and should be left unchanged.